What is Ashkan Ghorbani's NPI number?

Ashkan Ghorbani's National Provider Identifier (NPI) is 1851392039, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Ashkan Ghorbani's specialty?

Ashkan Ghorbani is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Ashkan Ghorbani located?

Ashkan Ghorbani's practice location on file with NPPES is 4419 Crenshaw Rd, Pasadena, TX 77504-3628.

What is Ashkan Ghorbani's phone number?

The practice phone number listed in the NPPES registry for Ashkan Ghorbani is (281) 991-5944.

Does Ashkan Ghorbani accept Medicare?

Ashkan Ghorbani is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Ashkan Ghorbani's NPI active?

Yes — Ashkan Ghorbani's NPI (1851392039) is active in the NPPES registry as of the last update on 2024-04-09.

IndividualActiveAccepts Medicare

Ashkan Ghorbani, MD

NPI 1851392039 · Dermatology Physician · Pasadena, TX

Ashkan Ghorbani, MD is a Dermatology Physician provider in Pasadena, TX (NPI 1851392039).

Provider details

NPI number: 1851392039
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Male
Sole proprietor: No
License: K2475 (TX)

Practice location

4419 Crenshaw Rd

Pasadena, TX 77504-3628

Phone: (281) 991-5944

Fax: (281) 991-6129

Street-level locationGet directions

More TX providers

Mailing address

4419 Crenshaw Rd

Pasadena, TX 77504-3628

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense K2475 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(94/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
12,770 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	5,950	$7
Destruction of Skin Growth, 1-14 Growths17110	1,234	$112
Destruction of Precancer Skin Growth, 1 Growth17000	1,047	$42
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	1,038	$134
Destruction of Precancer Skin Growth, 15 Or More Growths17004	938	$175
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 25 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Metronidazole	663	397
Hydrocortisone	466	360
Ciclopirox Olaminebrand: Ciclopirox	418	218
Triamcinolone Acetonide	229	188
Mupirocin	118	75
Clobetasol Propionate	113	83
Fluocinonide	93	71
Terbinafine Hcl	77

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$5,334 across 292 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-08-10
Last updated: 2024-04-09
Certified: 2024-04-09

Frequently asked questions

What is Ashkan Ghorbani's NPI number?: Ashkan Ghorbani's National Provider Identifier (NPI) is 1851392039, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Ashkan Ghorbani's specialty?: Ashkan Ghorbani is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Ashkan Ghorbani located?: Ashkan Ghorbani's practice location on file with NPPES is 4419 Crenshaw Rd, Pasadena, TX 77504-3628.
What is Ashkan Ghorbani's phone number?: The practice phone number listed in the NPPES registry for Ashkan Ghorbani is (281) 991-5944.
Does Ashkan Ghorbani accept Medicare?: Ashkan Ghorbani is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Ashkan Ghorbani's NPI active?: Yes — Ashkan Ghorbani's NPI (1851392039) is active in the NPPES registry as of the last update on 2024-04-09.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	5,950	$7
Destruction of Skin Growth, 1-14 Growths17110	1,234	$112
Destruction of Precancer Skin Growth, 1 Growth17000	1,047	$42
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	1,038	$134
Destruction of Precancer Skin Growth, 15 Or More Growths17004	938	$175
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213

Drug

Part D claims (2024)

Beneficiaries

Metronidazole

663

397

Hydrocortisone

466

360

Ciclopirox Olaminebrand: Ciclopirox

418

218

Triamcinolone Acetonide

229

188

Mupirocin

118

Clobetasol Propionate

113

Fluocinonide

Terbinafine Hcl

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$5,334 across 292 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments